HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jomain-Baum, M. Articles by Hanson, R. W. Search for Related Content PubMed PubMed Citation Articles by Jomain-Baum, M. Articles by Hanson, R. W. Social Bookmarking                      What's this?

JBC, Vol. 251, Issue 1, 37-44, Jan, 1976

Mechanism of 3-mercaptopicolinic acid inhibition of hepatic phosphoenolpyruvate carboxykinase (GTP)

M. Jomain-Baum, V. L. Schramm and R. W. Hanson

The hypoglycemic agent 3-mercaptopicolinic acid inhibits gluconeogenesis from lactate by isolated, perfused livers from fasted rats and guinea pigs. A 3-mercaptopicolinate concentration of 50 muM caused a sharp decrease in glucose synthesis, with virtually complete inhibition at 100 muM. This inhibitory effect was reversed completely when 3-mercaptopicolinate was removed and the rate of glucose synthesis returned to normal values within 2 min. Oxygen consumption was not altered, even at the highest concentration of inhibitor. Gluconeogenesis from glycerol by guinea pig liver was blocked completely by 100 muM 3-mercaptopicolinate but was inhibited only partially in rat liver. After removal of the inhibitor glucose synthesis returned to levels higher than noted before the addition of this compound. The formation of P-enolpyruvate bu isolated guinea pig liver mitochondria metabolizing alpha-ketoglutarate (State 3) was inhibited markedly by 3-mercaptopicolinate, but malate conversion to P-enolpyruvate was considerably less sensitive. Kinetic studies with purified P-enolpyruvate carboxykinase from rat liver cytosol indicate that 3-mercaptopicolinate is a noncompetitive inhibitor with respect to both oxalacetate and MnGTP2-, and that simulataeous saturation with both substrates does not diminish this inhibition. The inhibitory effects of 3-mercaptopicolinate occur primarily by decreasing the rate of product formation while having relatively minor effects on the apparent Michaelis constants for substrates. Inhibition constants for slope and intercept effects ranged from 3 to 9 muM 3-mercaptopicolinate, and the inhibition patterns were dependent on the concentration of free Mn2+ present. Comparison of the inhibition constants with the observed inhibition of gluconeogenesis in livers perfused with 3-mercaptopicolinate supports the contention that P-enolpyruvate carboxykinase is the site of action of this inhibitor. The possibility that 3-mercaptopicolinate inhibition occurs by binding either free or bound manganese was eliminated by determination of the dissociation constant of 0.51 mM for the manganese-3-mercaptopicolinate complex. In addition, no tightly bound, slowly exchanging metal was bound to purified enzyme protein. These results suggest that 3-mercaptopicolinate inhibits by the removal of a tightly bound, rapidly exchanging metal ion other than Mn2+.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. Yang, R. S. Kombu, T. Kasumov, S.-H. Zhu, A. V. Cendrowski, F. David, V. E. Anderson, J. K. Kelleher, and H. Brunengraber Metabolomic and Mass Isotopomer Analysis of Liver Gluconeogenesis and Citric Acid Cycle: I. INTERRELATION BETWEEN GLUCONEOGENESIS AND CATAPLEROSIS; FORMATION OF METHOXAMATES FROM AMINOOXYACETATE AND KETOACIDS J. Biol. Chem., August 8, 2008; 283(32): 21978 - 21987. [Abstract] [Full Text] [PDF]

				L. Yang, T. Kasumov, R. S. Kombu, S.-H. Zhu, A. V. Cendrowski, F. David, V. E. Anderson, J. K. Kelleher, and H. Brunengraber Metabolomic and Mass Isotopomer Analysis of Liver Gluconeogenesis and Citric Acid Cycle: II. HETEROGENEITY OF METABOLITE LABELING PATTERN J. Biol. Chem., August 8, 2008; 283(32): 21988 - 21996. [Abstract] [Full Text] [PDF]

				P. Hakimi, J. Yang, G. Casadesus, D. Massillon, F. Tolentino-Silva, C. K. Nye, M. E. Cabrera, D. R. Hagen, C. B. Utter, Y. Baghdy, et al. Overexpression of the Cytosolic Form of Phosphoenolpyruvate Carboxykinase (GTP) in Skeletal Muscle Repatterns Energy Metabolism in the Mouse J. Biol. Chem., November 9, 2007; 282(45): 32844 - 32855. [Abstract] [Full Text] [PDF]

				M. Croset, F. Rajas, C. Zitoun, J.-M. Hurot, S. Montano, and G. Mithieux Rat Small Intestine Is an Insulin-Sensitive Gluconeogenic Organ Diabetes, April 1, 2001; 50(4): 740 - 746. [Abstract] [Full Text]

				A. Wingler, R. P. Walker, Z.-H. Chen, and R. C. Leegood Phosphoenolpyruvate Carboxykinase Is Involved in the Decarboxylation of Aspartate in the Bundle Sheath of Maize Plant Physiology, June 1, 1999; 120(2): 539 - 546. [Abstract] [Full Text]